is retatrutide safe for type 1 diabetes Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide vs Survodutide: 24% vs

9 Additionally, it has been shown to reduce the risk of developing T2D by 60%, regardless of whether patients have prediabetes or normal blood sugar levels

All others declare no competing interests

143 The safety profile of tirzepatide is similar to other drugs in its class, providing an effective new treatment option for patients with T2DM and obesity

While studies sponsored by leading pharmaceutical companies suggest a much higher likelihood of weight regain, those studies are not reflective of the average person with obesity

Retatrutide is investigational and meets neither requirement

Hui, H., Nourparvar, A., Zhao, X